Filters
reset allOther countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
High-Resolution Rapid Microarray (CGH and SNP) Allele Diagnostics United States | 247 | 231 |
|
Rapid microarray (CGH and SNP) Allele Diagnostics United States | 247 | 231 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
Common Hereditary Cancer Screening Panel PreventionGenetics United States | 94 | 55 |
|
MITF - NGS including CNV analysis Centogene US, LLC - The Rare Disease Company United States | 4 | 1 |
|
MITF - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 4 | 1 |
|
Invitae Hypopigmentation Panel Invitae United States | 83 | 46 |
|
Invitae Comprehensive Deafness Panel Invitae United States | 405 | 219 |
|
Microphthalmia/Anophthalmia/Coloboma Panel PreventionGenetics United States | 73 | 55 |
|
Waardenburg syndrome, type 2A, 193510, Autosomal dominant; WS2A (Waardenburg syndrome type 2) (MLPA) Intergen Genetic Diagnosis and Research Centre Turkey | 1 | 1 |
|
Intergen Genetic Diagnosis and Research Centre Turkey | 1 | 1 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
Variant Resolution Test for CustomNext-Cancer® (+RNAinsight®) Ambry Genetics United States | 147 | 18 |
|
Variant Resolution Test for MelanomaNext® (+RNAinsight®) Ambry Genetics United States | 40 | 3 |
|
Variant Resolution Test for CancerNext-Expanded® (+RNAinsight®) Ambry Genetics United States | 141 | 18 |
|
Hereditary Hearing Loss and Deafness Panel PreventionGenetics United States | 356 | 211 |
|
Anterior Segment Dysgenesis Disorders Panel PreventionGenetics United States | 270 | 276 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.